Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 113, Issue 3, 2013, Pages 158-166

  Abdel Raheem, Ihab T ^a   Taye, Ashraf ^b   Abouzied, Mekky M ^b  

^a Damanhour University   (Egypt)

^b Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CREATINE KINASE; DOXORUBICIN; GLIBENCLAMIDE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LIPID PEROXIDE; NICORANDIL; NITRATE; NITRITE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVITY; HEART PROTECTION; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; TISSUE DEGENERATION; WEIGHT REDUCTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; GLUTATHIONE; GLYBURIDE; LIPID PEROXIDATION; MALE; NF-KAPPA B; NICORANDIL; RATS; RATS, WISTAR; SUPEROXIDES; WEIGHT LOSS;

RATTUS;

EID: 84880701913     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12078     Document Type: Article

References (54)

1. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003;97:2869-79.
2. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007;50:1435-41.
3. Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS, Osman AM. Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 2010;48:951-6.
4. Simunek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 2009;61:154-71.
5. Montaigne D, Hurt C, Neviere R. Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int 2012;2012:951539-44.
6. Fogli S, Nieri P, Breschi MC. The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J 2004;18:664-75.
7. Dozor AJ. The role of oxidative stress in the pathogenesis and treatment of asthma. Ann N Y Acad Sci 2010;1203:133-7.
8. Kim DS, Woo ER, Chae SW, Ha KC, Lee GH, Hong ST et al. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Life Sci 2007;80:314-23.
9. Miura T, Miki T. ATP-sensitive K+ channel openers: old drugs with new clinical benefits for the heart. Curr Vasc Pharmacol 2003;1:251-8.
10. Wan Mohamad WB, Tun Fizi A, Ismail RB, Mafauzy M. Efficacy and safety of single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus. Diabetes Res Clin Pract 2000;49:93-9.
11. ATP) channel activation decreases intraocular pressure in the anterior chamber of the eye. Invest Ophthalmol Vis Sci 2011;52:6435-42.
12. Li Q, Sanlioglu S, Li S, Ritchie T, Oberley L, Engelhardt JF. GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex. Antioxid Redox Signal 2001;3:415-32.
13. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989;63:18J-24J.
14. Das B, Sarkar C. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model. Life Sci 2005;77:1226-48.
15. Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Shimizu M, Nishii T et al. Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin. J Am Coll Cardiol 2001;37:719-25.
16. ATP channel. Clin Chim Acta 2006;374:100-5.
17. Date T, Taniguchi I, Inada K, Matsuo S, Miyanaga S, Yamane T et al. Nicorandil inhibits serum starvation-induced apoptosis in vascular endothelial cells. J Cardiovasc Pharmacol 2005;46:721-6.
18. Kasono K, Yasu T, Kakehashi A, Kinoshita N, Tamemoto H, Namai K et al. Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitro. Eur J Endocrinol 2004;151:277-85.
19. Hongo M, Mawatari E, Sakai A, Ruan Z, Koizumi T, Terasawa F et al. Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats. J Cardiovasc Pharmacol 2005;46:452-8.
20. Kawamura, Kadosaki M, Nara N, Wei J, Endo S, Inada K. Nicorandil attenuates NF-kappaB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery. Shock 2005;24:103-8.
21. Ahmed LA, Salem HA, Attia AS, Agha AM. Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. Eur J Pharmacol 2011;663:51-8.
22. Hai S, Takemura S, Minamiyama Y, Yamasaki K, Yamamoto S, Kodai S et al. Mitochondrial K(ATP) channel opener prevents ischemia-reperfusion injury in rat liver. Transplant Proc 2005;37:428-31.
23. Sakai K, Tsuchiya Y, Kitajima S, Hamada H. Myocardial distribution and biotransformation in vitro and in vivo of nicorandil in rats, with special reference to mitochondria. J Cardiovasc Pharmacol 1999;33:163-8.
24. Fouad AA, Yacoubi MT. Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity. Arch Pharm Res 2011;34:821-8.
25. Nozaki N, Shishido T, Takeishi Y, Kubota I. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 2004;110:2869-74.
26. Horinaka S, Kobayashi N, Higashi T, Hara K, Hara S, Matsuoka H. Nicorandil enhances cardiac endothelial nitric oxide synthase expression via activation of adenosine triphosphate-sensitive K channel in rat. J Cardiovasc Pharmacol 2001;38:200-10.
27. Whitaker JF. A general colorimetric procedure for the estimation of enzymes which are linked to the NADH-NAD+ system. Clin Chim Acta 1969;24:23-37.
28. Bishop C, Chu TM, Shihabi ZK. Single stable reagent for creatine kinase assay. Clin Chem 1971;17:548-50.
29. Abdel-Raheem IT. Gastroprotective effect of rutin against indomethacin-induced ulcers in rats. Basic Clin Pharmacol Toxicol 2010;107:742-50.
30. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
31. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.
32. Taye A, Saad AH, Kumar AH, Morawietz H. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol 2010;627:42-8.
33. Bancroft J, Stevens A. Connective tissues and stains. In: Stevens A (ed). Theory and Practice of Histological Techniques. Churchill Livingstone, UK, 1994;129-34.
34. Todorova VK, Kaufmann Y, Hennings L, Klimberg VS. Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. J Nutr 2010;140:448-53.
35. Yamanaka S, Tatsumi T, Shiraishi J, Mano A, Keira N, Matoba S et al. Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes. J Am Coll Cardiol 2003;41:870-8.
36. Alimoradi H, Barzegar-Fallah A, Hassanzadeh G, Mohammadi-Rick S, Asadi F, Delfan B et al. The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin. Cardiovasc Toxicol 2012;12:318-25.
37. El Boghdady NA. Antioxidant and antiapoptotic effects of proanthocyanidin and ginkgo biloba extract against doxorubicin-induced cardiac injury in rats. Cell Biochem Funct 2012. doi: 10.1002/cbf.2907. [Epub ahead of print].
38. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 2002;109:735-43.
39. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001;103:1282-8.
40. Oteki T, Nagase S, Shimohata H, Hirayama A, Ueda A, Yokoyama H et al. Nitric oxide protection against adriamycin-induced tubulointerstitial injury. Free Radic Res 2008;42:154-61.
41. Gilleron M, Marechal X, Montaigne D, Franczak J, Neviere R, Lancel S. NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis. Biochem Biophys Res Commun 2009;388:727-31.
42. Takacs IE, Matkovics B, Varga SI, Homolay P, Feer G, Seres T. Study of the myocardial antioxidant defense in various species. Pharmacol Res 1992;25:177-8.
43. Hershman DL, Shao T. Anthracycline cardiotoxicity after breast cancer treatment. Oncology (Williston Park) 2009;23:227-34.
44. Alshabanah OA, Hafez MM, Al-Harbi MM, Hassan ZK, Al Rejaie SS, Asiri YA et al. Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxid Med Cell Longev 2010;3:428-33.
45. Abdel-Raheem IT, Abdel-Ghany AA. Hesperidin alleviates doxorubicin-induced cardiotoxicity in rats. J Egypt Natl Canc Inst 2009;21:175-84.
46. Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, Kalyanaraman B. Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem J 2002;367:729-40.
47. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K et al. Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001;38:48-55.
48. Arlt A, Vorndamm J, Breitenbroich M, Folsch R, Kalthoff H, Schmidt WE et al. Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 2001;20:859-68.
49. Singh N, Kumar R. Effect of nicorandil and amlodipine on bio-chemical parameters during isoproterenol induced myocardial necrosis in rats. Indian J Clin Biochem 2003;18:99-102.
50. ATP channel. Eur J Pharmacol 2008;579:86-92.
51. Eguchi Y, Takahari Y, Higashijima N, Ishizuka N, Tamura N, Kawamura Y et al. Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production. Circ J 2009;73:554-61.
52. Serizawa K, Yogo K, Aizawa K, Tashiro Y, Ishizuka N. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. Cardiovasc Diabetol 2011;10:105-9.
53. Liou JY, Hong HJ, Sung LC, Chao HH, Chen PY, Cheng TH et al. Nicorandil inhibits angiotensin-II-induced proliferation of cultured rat cardiac fibroblasts. Pharmacology 2011;87:144-51.
54. ATP channel opener, prevents paclitaxel-induced endothelial dysfunction in rats. Eur J Cardiol 2010;31:99-103.